ArticleGynecologic oncology reports2023

SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color.

A B Pierre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.